% of Cases treated with Surgery
| Country average (population) | Country average (country) | England | Scotland | Northern Ireland | Wales | Republic of Ireland | |
|---|---|---|---|---|---|---|---|
| All invasive xnmsc | 48.9% | 48.5% | 49.5% | 42.0% | 54.0% | ||
| All xnmsc 0-24 | 52.1% | 51.6% | 52.1% | 53.8% | 48.9% | ||
| All xnmsc 25-59 | 66.9% | 66.6% | 67.4% | 61.7% | 70.6% | ||
| All xnmsc 60-79 | 48.4% | 47.2% | 49.1% | 39.9% | 52.6% | ||
| All xnmsc 80+ | 30.5% | 30.6% | 31.0% | 23.7% | 37.1% | ||
| Haematology | 6.2% | 7.7% | 6.1% | 6.9% | 10.2% | ||
| Head and Neck | 53.9% | 52.2% | 54.9% | 45.4% | 56.4% | ||
| Lower GI | 68.1% | 69.1% | 68.5% | 60.7% | 78.0% | ||
| Upper GI | 36.2% | 37.5% | 37.7% | 16.7% | 58.0% | ||
| HPB | 31.0% | 29.5% | 32.6% | 10.3% | 45.5% | ||
| Trachea, Bronchus & Lung | 24.8% | 22.0% | 26.3% | 13.2% | 26.6% | ||
| Melanoma of skin | 96.8% | 95.1% | 96.9% | 97.4% | 90.9% | ||
| Breast | 77.8% | 79.8% | 77.8% | 75.9% | 85.6% | ||
| Cervix | 64.3% | 63.9% | 65.3% | 55.8% | 70.7% | ||
| Other Female Genitals | 75.3% | 74.7% | 75.7% | 70.5% | 77.8% | ||
| Prostate | 22.3% | 18.6% | 23.0% | 15.7% | 17.0% | ||
| Kidney | 60.7% | 62.9% | 61.0% | 52.2% | 75.5% | ||
| Bladder | 85.4% | 84.9% | 86.1% | 77.5% | 91.0% | ||
| Brain and CNS | 48.8% | 51.0% | 48.5% | 50.8% | 53.8% | ||
| Thyroid & other endocrine glands | 87.8% | 86.0% | 88.4% | 80.3% | 89.3% | ||
| CUP | 13.2% | 12.5% | 13.9% | 5.1% | 18.4% | ||
| Other invasive cancer | 56.3% | 53.7% | 57.4% | 47.0% | 56.7% | ||
| Breast in situ | 88.7% | 88.6% | 88.6% | 91.5% | 85.8% | ||
| Cervix in situ | 86.8% | 66.2% | 88.7% | 97.6% | 12.4% | ||
| Other tumours | 64.0% | 61.9% | 63.9% | 70.6% | 51.1% | ||
| Non-Melanoma Skin Cancer | 42.2% | 61.4% | 37.4% | 92.1% | 54.7% |